AR038899A1 - Un medicamento para animales - Google Patents
Un medicamento para animalesInfo
- Publication number
- AR038899A1 AR038899A1 ARP030100790A ARP030100790A AR038899A1 AR 038899 A1 AR038899 A1 AR 038899A1 AR P030100790 A ARP030100790 A AR P030100790A AR P030100790 A ARP030100790 A AR P030100790A AR 038899 A1 AR038899 A1 AR 038899A1
- Authority
- AR
- Argentina
- Prior art keywords
- particles
- animal
- coated
- production
- active ingredient
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title abstract 7
- 229940126601 medicinal product Drugs 0.000 title 1
- 239000002245 particle Substances 0.000 abstract 7
- 239000003814 drug Substances 0.000 abstract 6
- 239000004480 active ingredient Substances 0.000 abstract 5
- 238000004519 manufacturing process Methods 0.000 abstract 4
- 239000000758 substrate Substances 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- 239000012876 carrier material Substances 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000007935 neutral effect Effects 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000011241 protective layer Substances 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 239000010410 layer Substances 0.000 abstract 1
- 244000144972 livestock Species 0.000 abstract 1
- 230000000873 masking effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000003296 saliva Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Abstract
Suministro y producción de un medicamento para animales que consiste en un sustrato en forma de gránulo o tableta, que es atractivo para el ganado y los animales domésticos, en donde se empotran partículas de grano fino de un material de vehículo sólido de sabor neutro, fisiológicamente compatible, que se caracteriza porque las partículas de grano fino del material de vehículo tienen un diámetro promedio de 0,09 a 0,8 milímetros, y se recubren con una sustancia activa de medicina veterinaria, y esta capa de sustancia activa se cubre con una capa protectora de una matriz polimérica fisiológicamente compatible y a la producción de este medicamento para animales. Uso de estas partículas de grano fino doblemente recubiertas de material de vehículo en la producción de una preparación para medicina veterinaria. Reivindicación (10): Un proceso para la producción de un medicamento para animales de acuerdo con una de las reivindicaciones 1 a 9, caracterizado porque: (1) se recubren partículas con un diámetro promedio de 0,09 a 0,8 milímetros de un material de vehículo sólido de sabor neutro, fisiológicamente compatible, con un ingrediente activo o una mezcla de ingredientes activos para medicina veterinaria, de tal manera que el ingrediente activo encierre a las partículas. (2) este recinto de ingrediente activo se recubre con una capa protectora enmascaradora consistente en una matriz polimérica fisiológicamente compatible, la cual impide el contacto directo del ingrediente activo con las células gustativas y olfativas y la saliva del animal; (3) estas partículas doblemente recubiertas se mezclan íntimamente con un sustrato que sea atractivo para el animal; y (4) la mezcla consistente en sustrato y partículas doblemente recubiertas se comprime en unidades administrables de un tamano apropiado.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02005511 | 2002-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR038899A1 true AR038899A1 (es) | 2005-02-02 |
Family
ID=27798784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030100790A AR038899A1 (es) | 2002-03-11 | 2003-03-07 | Un medicamento para animales |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20050169971A1 (es) |
| EP (2) | EP1803448A3 (es) |
| JP (1) | JP4663985B2 (es) |
| KR (1) | KR20040101302A (es) |
| CN (1) | CN1652754B (es) |
| AR (1) | AR038899A1 (es) |
| AT (1) | ATE390129T1 (es) |
| AU (1) | AU2003218722B2 (es) |
| BR (1) | BR0308378B1 (es) |
| CA (1) | CA2478811C (es) |
| CO (1) | CO5400144A1 (es) |
| DE (1) | DE60319969T2 (es) |
| DK (1) | DK1490037T3 (es) |
| ES (1) | ES2301784T3 (es) |
| MX (1) | MXPA04008845A (es) |
| NZ (1) | NZ535167A (es) |
| PT (1) | PT1490037E (es) |
| RU (1) | RU2318498C2 (es) |
| SI (1) | SI1490037T1 (es) |
| TW (1) | TWI309557B (es) |
| WO (1) | WO2003075895A1 (es) |
| ZA (1) | ZA200407010B (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050169941A1 (en) * | 2004-01-29 | 2005-08-04 | Andrew Lees | Use of amino-oxy functional groups in the preparation of protein-polysaccharide conjugate vaccines |
| EP1579862A1 (en) | 2004-03-25 | 2005-09-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
| US8980894B2 (en) | 2004-03-25 | 2015-03-17 | Boehringer Ingelheim Vetmedica Gmbh | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure |
| WO2005123045A2 (en) * | 2004-06-10 | 2005-12-29 | Glatt Air Techniques, Inc. | Controlled release matrix pharmaceutical dosage formulation |
| EP1753405A4 (en) * | 2004-06-10 | 2008-09-17 | Glatt Air Tech Inc | SLOW RELEASE PHARMACEUTICAL PREPARATION |
| EP1920785A1 (en) | 2006-11-07 | 2008-05-14 | Boehringer Ingelheim Vetmedica Gmbh | Liquid preparation comprising a complex of pimobendan and cyclodextrin |
| EP1935405A1 (en) * | 2006-12-22 | 2008-06-25 | LEK Pharmaceuticals D.D. | Orally disintegrating tablets |
| JP2014521714A (ja) | 2011-08-12 | 2014-08-28 | ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング | ネコ科動物の心不全を治療および予防する方法において使用するための奇異性電流（Ｉｆ）阻害薬 |
| AU2012307656B2 (en) | 2011-09-15 | 2016-07-07 | Friulchem Spa | Compositions for oral administration to animals, production methods thereof and uses of same |
| WO2014033230A1 (fr) | 2012-08-31 | 2014-03-06 | Friulchem Spa | Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations |
| CZ308210B6 (cs) * | 2011-11-02 | 2020-03-04 | Veterinární A Farmaceutická Univerzita Brno | Farmaceutická kompozice ve formě pelet majících velikost částic v rozmezí od 0,1 do 10 mm pro perorální podání vodním živočichům a způsob její výroby |
| ES2656412T3 (es) | 2011-12-21 | 2018-02-27 | Elanco Tiergesundheit Ag | Nueva combinación |
| WO2013135852A1 (en) * | 2012-03-15 | 2013-09-19 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof |
| WO2013135853A1 (en) * | 2012-03-15 | 2013-09-19 | Boehringer Ingelheim Vetmedica Gmbh | Pharmaceutical packaging product for the veterinary medical sector |
| CL2013001262A1 (es) * | 2012-05-08 | 2013-09-27 | Novartis Ag | Uso de lufenuron para control de los piojos marinos en una poblacion de peces; alimento para peces que comprende lufenuron. |
| FR2991179B1 (fr) * | 2012-06-01 | 2016-11-11 | Ceva Sante Animale | Compositions veterinaires orales appetentes |
| WO2014053555A1 (en) | 2012-10-04 | 2014-04-10 | Novartis Ag | Veterinary drug system |
| FR3002735B1 (fr) | 2013-03-04 | 2015-07-03 | Virbac | Composition orale nutritionnelle et medicamenteuse a usage veterinaire |
| FR3002736B1 (fr) | 2013-03-04 | 2015-06-26 | Virbac | Composition orale nutritionnelle et medicamenteuse a usage veterinaire |
| CA2915445C (en) | 2013-07-19 | 2024-04-23 | Boehringer Ingelheim Vetmedica Gmbh | Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition |
| EA201992230A1 (ru) | 2013-12-04 | 2020-02-28 | Бёрингер Ингельхайм Ветмедика Гмбх | Улучшенные фармацевтические композиции пимобендана |
| KR101687973B1 (ko) * | 2015-12-08 | 2016-12-21 | 주식회사 씨티씨바이오 | 마이크로필름 코팅을 이용한 동물 사료용 프리믹스 제조방법 |
| US10537570B2 (en) | 2016-04-06 | 2020-01-21 | Boehringer Ingelheim Vetmedica Gmbh | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease |
| CN105963270B (zh) * | 2016-06-30 | 2019-01-15 | 齐鲁动物保健品有限公司 | 一种盐酸贝那普利软咀嚼片及其制备方法 |
| CN109673848A (zh) * | 2018-12-29 | 2019-04-26 | 广州智特奇生物科技股份有限公司 | 一种肠溶包被材料、肠道缓释单宁酸及其制备方法 |
| JP7534139B2 (ja) * | 2020-07-03 | 2024-08-14 | 獣医医療開発株式会社 | 動物用医薬製剤 |
| CN112220769A (zh) * | 2020-08-13 | 2021-01-15 | 浙江海正动物保健品有限公司 | 一种米尔贝肟吡喹酮风味片及其制备方法 |
| US20230372249A1 (en) | 2020-09-04 | 2023-11-23 | Elanco Us Inc. | Palatable formulations |
| LT4037666T (lt) | 2020-12-08 | 2024-06-10 | Ruminant Biotech Corp Limited | Medžiagų pristatymo gyvūnams prietaisų ir būdų patobulinimai |
| CN113768038A (zh) * | 2021-09-14 | 2021-12-10 | 江苏省协同医药生物工程有限责任公司 | 一种精准定量实验动物功能性饲料及制备方法与设备 |
| JP7109827B1 (ja) * | 2021-11-16 | 2022-08-01 | 株式会社ハニック・ホワイトラボ | 抗ウイルス剤 |
| CN119033030A (zh) * | 2024-09-03 | 2024-11-29 | 江西省农业科学院畜牧兽医研究所 | 一种提高断奶仔猪生产性能的饲料添加剂 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3231466A (en) * | 1962-10-26 | 1966-01-25 | Walter H Hoffman | Composition and method for treating animals and poultry |
| US3824233A (en) * | 1972-07-06 | 1974-07-16 | Lilly Co Eli | Anthelmintic phenylhydrazones |
| US3937825A (en) * | 1973-09-21 | 1976-02-10 | American Cyanamid Company | Anthelmintic composition and method of use |
| US4708867A (en) * | 1983-12-19 | 1987-11-24 | Key Pharmaceuticals, Inc. | Minipellets |
| US4800087A (en) | 1986-11-24 | 1989-01-24 | Mehta Atul M | Taste-masked pharmaceutical compositions |
| JPS63188621A (ja) * | 1987-01-30 | 1988-08-04 | Taisho Pharmaceut Co Ltd | 矯味経口製剤 |
| JPH05506011A (ja) * | 1990-04-11 | 1993-09-02 | ジ・アップジョン・カンパニー | 流動床コーティングによるイブプロフェンの味覚マスキング |
| CA2137265C (en) * | 1992-06-04 | 2003-10-28 | Sanjay Bhardwaj | Palatable pharmaceutical compositions |
| SE9301489D0 (sv) * | 1993-04-30 | 1993-04-30 | Ab Astra | Veterinary composition |
| ES2167436T3 (es) * | 1994-05-20 | 2002-05-16 | Janssen Pharmaceutica Nv | Tabletas de flubendazol masticables para animales de compañia. |
| SE9402422D0 (sv) | 1994-07-08 | 1994-07-08 | Astra Ab | New beads for controlled release and a pharmaceutical preparation containing the same |
| SE9600071D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral formulation of two active ingredients I |
| DE69739394D1 (de) | 1996-10-16 | 2009-06-18 | Napo Pharmaceuticals Inc | Enteral-formulierungen von proanthocyanidzusammensetzungen gegen diarrhöe |
| US7399485B1 (en) * | 1998-07-28 | 2008-07-15 | Takeda Pharmaceutical Company Limited | Rapidly Disintegrable solid preparation |
| US5997905A (en) * | 1998-09-04 | 1999-12-07 | Mcneil-Ppc | Preparation of pharmaceutically active particles |
| US6432448B1 (en) * | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
| US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| GB2356346A (en) * | 1999-11-19 | 2001-05-23 | Mars Uk Ltd | Food product for oral delivery of a pharmaceutical agent to a non-human animal comprising encapsulated particles of said agent distributed within the product |
| US6541025B1 (en) * | 1999-12-30 | 2003-04-01 | Shear/Kershman Laboratories, Inc. | Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals |
| GB0008332D0 (en) * | 2000-04-04 | 2000-05-24 | Pfizer Ltd | Treament |
| EP1372412A2 (en) | 2001-03-09 | 2004-01-02 | Societe Des Produits Nestle S.A. | Composition improving age-related physiological deficits and increasing longevity |
| US20030190343A1 (en) * | 2002-03-05 | 2003-10-09 | Pfizer Inc. | Palatable pharmaceutical compositions for companion animals |
-
2003
- 2003-02-14 CO CO03012637A patent/CO5400144A1/es not_active Application Discontinuation
- 2003-03-07 AR ARP030100790A patent/AR038899A1/es not_active Application Discontinuation
- 2003-03-10 EP EP06123293A patent/EP1803448A3/en not_active Withdrawn
- 2003-03-10 TW TW092105075A patent/TWI309557B/zh not_active IP Right Cessation
- 2003-03-10 ES ES03711962T patent/ES2301784T3/es not_active Expired - Lifetime
- 2003-03-10 BR BRPI0308378-0B1A patent/BR0308378B1/pt active IP Right Grant
- 2003-03-10 DK DK03711962T patent/DK1490037T3/da active
- 2003-03-10 RU RU2004130433/15A patent/RU2318498C2/ru not_active IP Right Cessation
- 2003-03-10 KR KR10-2004-7014280A patent/KR20040101302A/ko not_active Ceased
- 2003-03-10 SI SI200331214T patent/SI1490037T1/sl unknown
- 2003-03-10 CA CA2478811A patent/CA2478811C/en not_active Expired - Lifetime
- 2003-03-10 JP JP2003574170A patent/JP4663985B2/ja not_active Expired - Lifetime
- 2003-03-10 NZ NZ535167A patent/NZ535167A/en not_active IP Right Cessation
- 2003-03-10 AU AU2003218722A patent/AU2003218722B2/en not_active Expired
- 2003-03-10 MX MXPA04008845A patent/MXPA04008845A/es active IP Right Grant
- 2003-03-10 US US10/506,937 patent/US20050169971A1/en not_active Abandoned
- 2003-03-10 PT PT03711962T patent/PT1490037E/pt unknown
- 2003-03-10 DE DE60319969T patent/DE60319969T2/de not_active Expired - Lifetime
- 2003-03-10 EP EP03711962A patent/EP1490037B1/en not_active Revoked
- 2003-03-10 WO PCT/EP2003/002446 patent/WO2003075895A1/en not_active Ceased
- 2003-03-10 AT AT03711962T patent/ATE390129T1/de active
- 2003-03-10 CN CN038105713A patent/CN1652754B/zh not_active Expired - Lifetime
-
2004
- 2004-09-02 ZA ZA200407010A patent/ZA200407010B/en unknown
-
2009
- 2009-12-03 US US12/630,422 patent/US8617587B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR038899A1 (es) | Un medicamento para animales | |
| ES2052656T3 (es) | Una formulacion de revestimiento para la encapsulacion de sustancias bioactivas. | |
| DK0495349T3 (da) | Aktivmiddelpræparat til oral indgivelse, især til drøvtyggere | |
| AR030557A1 (es) | Una tableta en multicapa de liberacion controlada y metodo de tratamiento | |
| EA200200595A1 (ru) | Лекарственная форма с высвобождением лекарства под действием гидрогеля | |
| CN103622917A (zh) | 基于微囊化亚硝酸盐和酸化水凝胶的延时产生一氧化氮的系统和方法 | |
| AR024384A1 (es) | UNA FORMA DE DOSIFICACIoN FARMACÉUTICA DE DISOLUCIoN INSTANTÁNEA Y UN MÉTODO PARA PREPARARLA | |
| DE69803360D1 (de) | Anwendungsformen zur behandlung der männlichen erektilen dysfunktion | |
| IS1694B (is) | Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara | |
| WO2005009357A3 (en) | Controlled release compositions | |
| RU2010147287A (ru) | Комбинированная композиция | |
| AR011133A1 (es) | MICROGRÁNULOS DE LIBERACIoN CONTROLADA QUE CONTIENEN CISPLATINO , PROCEDIMIENTO DE SU PREPARACIoN, COMPOSICIoN FARMACÉUTICA Y UTILIZACIoN EN LA FABRICACIoN DE UN MEDICAMENTO POLIQUIMIOTERAPIA O EN ASOCIACIoN CON UNA RADIOTERAPIA. | |
| WO2007067582A3 (en) | Process for manufacturing chewable dosage forms for drug delivery and products thereof | |
| Lee et al. | Advances of multifunctional hydrogels for periodontal disease | |
| ES2006649A6 (es) | Una composicion para depositarse sobre la superficie de un granulo de un producto farmaceutico y procedimiento para la obtencion de la misma. | |
| AR024564A1 (es) | Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico | |
| Torshabi et al. | In vitro behavior of poly‐lactic‐co‐glycolic acid microspheres containing minocycline, metronidazole, and ciprofloxacin | |
| AR036838A1 (es) | Comprimido de varias capas de liberacion controlada, uso del mismo para la fabricacion de un medicamento util en el tratamiento de la fibromialgia y composicion farmaceutica que lo comprende. | |
| EA201170784A1 (ru) | Гранулы тамсулозина для фиксированной комбинации | |
| GB2443793B (en) | Product, method of manufacture and use | |
| TW200635616A (en) | Organic compounds | |
| CN101048149A (zh) | 口腔内溶解用固体制剂 | |
| PE20040040A1 (es) | Unidades de dosificacion de progestagenico | |
| CN108096295A (zh) | 基于菠菜萃取物的凝胶和酸性微胶囊化粉末延长产生一氧化氮的系统和用品 | |
| CN108096297B (zh) | 包含微囊化的菠菜萃取物和酸性微囊化粉末的一氧化氮延时释放系统和成套用品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |